<DOC>
	<DOCNO>NCT00829881</DOCNO>
	<brief_summary>This study determine whether drug betahistine increase focus cause side effect people attention deficit hyperactivity disorder .</brief_summary>
	<brief_title>Effects Using Betahistine Treat Adults With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description>Attention deficit hyperactivity disorder ( ADHD ) disorder problem pay attention focus disrupt people 's life . Betahistine drug activates histamine , compound find human body regulate immune response act neurotransmitter . Increased availability histamine brain know enhance attention cognition . In previous study , betahistine increase vigilance healthy participant . Presently , betahistine use outside United States treat vertigo , dose low effect attention cognition . Based data regard use betahistine outside United States data study use betahistine , appear significant side effect use low dos . This study determine whether betahistine effective increase vigilance people ADHD whether side effect higher dos . Participation study last approximately 4 week . Participants first attend screen visit include review medical psychiatric history , physical examination , vital sign measurement , electrocardiogram ( EKG ) test , blood urine sample collection , eat questionnaire , clinical interview confirm ADHD diagnosis . Eligible participant randomly assign receive either betahistine placebo subsequent study visit . Participants attend three weekly study visit , start 1 week complete screening . At visit , participant receive dose either betahistine placebo . The dose betahistine increase visit , start 50 mg , increase 100 mg , 200 mg . Participants ask refrain eat drink water 12 hour prior study visit . Also visit , participant vital sign measure , complete questionnaire concern appetite mood , perform attention memory test , provide several blood sample , undergo EKG test , perform breathe test . Some test repeat several time course study visit . Additionally , last study visit , participant undergo physical examination provide urine sample .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Betahistine</mesh_term>
	<criteria>Diagnosis attention deficit hyperactivity disorder ( ADHD ) , combine subtype , use DSMIV criterion Otherwise healthy , determined medical history , physical examination , clinical laboratory test Symptomatic impairment ADHD , evidence symptom severity score 20 great 18item ADHD total symptom score Conners Adult ADHD Rating Scales ( CAARS ) Body mass index ( BMI ) less equal 32.4 kg/m2 , waist circumference less equal 40 inch male Known allergy betahistine Participation study involve administration investigational compound within past month Pregnant Positive HIV , hepatitis B antigen , hepatitis C antibody Use illicit drug ( exclude psychostimulants ADHD ) alcohol History drug addiction alcohol abuse require treatment within past 12 month History asthma , peptic ulcer disease , pheochromocytoma History illness condition , opinion principal investigator , might interfere study participation , confound result study , pose additional risk subject</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Attention</keyword>
</DOC>